A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-κB Signaling Pathways
Though the detailed pathological mechanism of post-infectious irritable bowel syndrome (PI-IBS) remains unclear, accumulating evidence indicates that oxidative stress and inflammation are implicated in the process of PI-IBS. Oxidative stress and inflammation are regulated by Nrf2 and NF-κB signaling...
Main Authors: | Li Zeng, Kaixue Li, Hong Wei, Jingjing Hu, Lu Jiao, Shaoyong Yu, Ying Xiong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2018.00272/full |
Similar Items
-
Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
by: Hatano Manabu, et al.
Published: (2004-11-01) -
EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
by: Mario Cioce, et al.
Published: (2021-02-01) -
Inhibition of EphA2 by Dasatinib Suppresses Radiation-Induced Intestinal Injury
by: Areumnuri Kim, et al.
Published: (2020-11-01) -
Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents
by: Ahmed F. Salem, et al.
Published: (2020-05-01) -
Targeting EphA2 in cancer
by: Ta Xiao, et al.
Published: (2020-08-01)